| 1/15 | US=16 / Biol/Mol Louro ID. Apoptose. In: Louro ID, Llerena Jr JC, Melo MSV, Ashton-Prolla P, Conforti-Froes N. Genética molecular do câncer. São Paulo: MSG Produções, 2002. p. 91-100. BCL-2; ICE; APOPTOSE; CANCER; MIMETISMO VIRAL; SINAIS DE SOBREVIVENCIA CELULAR; ONCOGENES; RESISTENCIA A QUIMIOTERAPICOS |
| 2/15 | US=22 / Câncer Devita Jr VT, Chu R. Biology of drug resistance. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 343-9. |
| 3/15 | US=8 / Laboratório Hockenbery DM, Korsmeyer SJ. Cell death. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 72-80. ISBN 978-0-443-06715-0. MORTE CELULAR; TURNOVER CELULAR; RENOVACAO CELULAR EPIDERMICA; RESPOSTA AO DANO CELULAR; APOPTOSE; CASPASES; ATIVACAO DE PRO-CASPASES; APOPTOSSOMAS; BCL-2; BH3; VIAS DE APOPTOSE; DANOS AO DNA; RESPOSTA A PROTEINAS DESDOBRADAS (UPR); ONCOGENE; SINALIZADORAS DE SOBREVIVENCIA |
| 4/15 | US=45 / Biol/Mol Werner E. How cancer cells escape death. In: Apte SP, Sarangarajan R, editors. Cellular respiration and carcinogenesis. New Jersey: Humana Press, 2009. p. 161-78. ISBN 978-1-934115-07-7. BCL-2; CELULAS CANCEROSAS ESCAPAR DA MORTE; APOPTOSE; MITOCONDRIAS; PRO-SURVIVAL; AMBIENTE; GLICOLISE |
| 5/15 | US=60 / Biol/Mol Redondo M, Fúnez R, Esteban F. Apoptosis in the development and treatment of laryngeal cancer: role of p53, Bcl-2 and clusterin. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 237-49. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE LARINGE; P53; BCL-2; CLUSTERINA |
| 6/15 | US=85 / Biol/Mol Kim JY, Park HD, Park E, Chon JW, Park YK. Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells: second look at n-3 fatty acid. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 190-5. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. ALFA LINOLENICO-ACIDO; CELULAS CANCEROSAS DA MAMA; BAX; BCL-2; CITOCROMO C; CASPASE-3; POLI POLIMERASE (ADP-ROBOSI) |
| 7/15 | US=85 / Biol/Mol Shin DY, Ryu CH, Lee WS, Kim DC, Kim SH, Hah YS, Lee SJ, Shin SH, Kang HS, Choi YH. Induction of apoptosis and inhibition of invasion in human hepatoma cells by anthocyanins from Meoru. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 137-48. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. ANTOCIANINAS; APOPTOSE; INVASAO; CELULA HEP3B; BCL-2; CASPASES; CANCER |
| 8/15 | US=85 / Biol/Mol Jang YJ, Kim JE, Kang NJ, Lee KW, Lee HJ. Piceatannol attenuates 4-hydroxynonenal-induced apoptosis of PC12 cells by blocking activation of c-Jun N-terminal kinase. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 176-82. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. APOPTOSE; BCL-2; APOPTOSE; 4-HIDROXINONENAL; C-JUN N-TERMINAL QUINASE; PICEATANNOL |
| 9/15 | US=85 / Biol/Mol Kang MK, Kang NJ, Jang YJ, Lee KW, Lee HJ. Gallic acid induces neuronal cell death through activation of c-jun n-terminal kinase and downregulation of Bcl-2. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 514-20. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. |
| 10/15 | US=11 / Transplante Torlakovic EE, Naresh KN, Brunning RD. Other common markers. In: ___. Bone marrow immunohistochemistry. Chicago: American Society for Clinical Nutrition, 2009. p. 153-236. ISBN 978-0891895725. TRANSPLANTE; IMUNISTOQUIMICA; MEDULA OSSEA; MARCADORES; MIELOPEROXIDASE; HEMOGLOBINA A; HGBA; TRIPTASE DE MASTOCITOS; DESOXINUCLEOTIDIL TRANSFERASE TERMINAL; TDT; ANTIGENO RELACIONADO AO FATOR 8; FATOR DE VON WILLEBRAND; PAX-5; PU.1; FLI-1; CICLINA D1; LISOZIMA; BCL-6; IMUNOGLOBINAS; KI-67; MOLECULAS CITOTOXICAS; MARCADORES DE ESTROMA; MUM1; TRAP; BCL-2 |
| 11/15 | US=13 / Biol/Mol Pecorino L. Apoptosis. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 137-59. ISBN 978-0-19-921148-7. APOPTOSE; MECANISMOS MOLECULARES; VIA EXTRINSECA; VIA INTRISECA; RECEPTORES DE MORTE DA MEMBRANA; MITOCONDRIAS; GENE P53; CANCER; RECEPTORES TRAIL; QUIMIOTERAPIA; DROGAS ANTI-NEOPLASICAS APOPTOTICAS; BCL-2 |
| 12/15 | US=35 / Câncer Mesa RA, Kaufmann SH. Molecular foundations of AML pathogenesis and physiology: altered apoptosis in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 133-61. ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; APOPTOSE; RESISTENCIA MEDICAMENTOSA; BCL-2; MCL-1; XIAP; MICROAMBIENTE DA MEDULA OSSEA; RAS; FLT3 |
| 13/15 | US=92 / Biol/Mol Kaufmann SH. Apoptosis and alternative modes of cell death: the intrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 3-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CASPASES; CARCINOGENESE; BCL-2; AIP; RESISTENCIA AS DROGAS; DROGAS ANTICANCER |
| 14/15 | US=62 / Biol/Mol Hazlehurst LA. CAM-DR: hanging on for cell survival. In: Cress AE, Nagle RB. Cell adhesion and cytoskeletal molecules in metastasis. New York: Springer, 2006. p. 163-77. (Cancer Metastasis - Biology and Treatment, 9) ISBN 978-1-4020-5128-9. CAM-DR; SOBREVIVENCIA CELULAR; INTEGRINA BETA 1; BCL-2; BIM; RESISTENCIA AS DROGAS; CICLO CELULAR |
| 15/15 | US=123-A / Câncer Ornellas P, Ornellas AA, Alves G. Aspectos moleculares do câncer de pênis. In: Figueiredo EMA, Correia MM, Oliveira AF. Tratado de oncologia. Rio de Janeiro: Revinter, 2013. p. 1617-23. ISBN 978-85-37205402. NEOPLASIAS PENIANAS. GENETICA; CITOGENETICA; IMUNO-HISTOQUIMICA; CARCINOMA; GENES P53; TELOMERASE; BAX; BCL-2 |